HEADER TOXIN 25-AUG-99 1CW6 TITLE REFINED SOLUTION STRUCTURE OF LEUCOCIN A COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYPE IIA BACTERIOCIN LEUCOCIN A; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: LEUCOCIN A-UAL 187 SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: LEUCONOSTOC GELIDUM; SOURCE 3 ORGANISM_TAXID: 1244 KEYWDS ANTIMICROBIAL PEPTIDE, BACTERIOCIN, TOXIN EXPDTA SOLUTION NMR NUMMDL 18 AUTHOR Y.WANG,M.E.HENZ,N.L.F.GALLAGHER,S.CHAI,L.Z.YAN,A.C.GIBBS,M.E.STILES, AUTHOR 2 D.S.WISHART,J.C.VEDERAS REVDAT 6 13-NOV-24 1CW6 1 REMARK REVDAT 5 16-FEB-22 1CW6 1 REMARK REVDAT 4 24-FEB-09 1CW6 1 VERSN REVDAT 3 01-APR-03 1CW6 1 JRNL REVDAT 2 02-APR-00 1CW6 1 JRNL REMARK REVDAT 1 08-SEP-99 1CW6 0 JRNL AUTH Y.WANG,M.E.HENZ,N.L.GALLAGHER,S.CHAI,A.C.GIBBS,L.Z.YAN, JRNL AUTH 2 M.E.STILES,D.S.WISHART,J.C.VEDERAS JRNL TITL SOLUTION STRUCTURE OF CARNOBACTERIOCIN B2 AND IMPLICATIONS JRNL TITL 2 FOR STRUCTURE-ACTIVITY RELATIONSHIPS AMONG TYPE IIA JRNL TITL 3 BACTERIOCINS FROM LACTIC ACID BACTERIA. JRNL REF BIOCHEMISTRY V. 38 15438 1999 JRNL REFN ISSN 0006-2960 JRNL PMID 10569926 JRNL DOI 10.1021/BI991351X REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR 3.85, X-PLOR 3.85 REMARK 3 AUTHORS : BRUNGER (X-PLOR), BRUNGER (X-PLOR) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REMARK 3 THE REFINED STRUCTURES ARE BASED ON A TOTAL OF 434 INTERPROTON REMARK 3 DISTANCE REMARK 3 RESTRAINTS, 27 3JHNHA COUPLING CONSTANT RESTRAINTS, AND 136 PROTON REMARK 3 CHEMICAL REMARK 3 SHIFT RESTRAINTS REMARK 4 REMARK 4 1CW6 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 26-AUG-99. REMARK 100 THE DEPOSITION ID IS D_1000009583. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 2.8 REMARK 210 IONIC STRENGTH : 0 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 2MM LEUCOCIN A IN 90% TFE-D3,10% REMARK 210 H2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ REMARK 210 SPECTROMETER MODEL : UNITY REMARK 210 SPECTROMETER MANUFACTURER : VARIAN REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : VNMR 5.1 REMARK 210 METHOD USED : SIMULATED ANNEALING REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 18 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 18 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH ACCEPTABLE REMARK 210 COVALENT GEOMETRY,STRUCTURES REMARK 210 WITH FAVORABLE NON- BOND ENERGY, REMARK 210 STRUCTURES WITH THE LEAST REMARK 210 RESTRAINT VIOLATIONS,STRUCTURES REMARK 210 WITH THE LOWEST ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 9 REMARK 210 REMARK 210 REMARK: REMARK 210 THIS STRUCTURE WAS DETERMINED USING STANDARD 2D HOMONUCLEAR REMARK 210 TECHNIQUES. THE REMARK 210 STRUCTURE WAS DETERMINED USING TRIPLE-RESONANCE NMR SPECTROSCOPY. REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O TRP A 18 H PHE A 22 1.47 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 TYR A 3 40.34 -109.73 REMARK 500 1 ASN A 5 52.42 -145.80 REMARK 500 1 LYS A 11 34.77 36.10 REMARK 500 1 SER A 12 47.00 74.04 REMARK 500 1 TRP A 18 -65.14 64.07 REMARK 500 1 ASN A 34 -61.12 66.11 REMARK 500 1 PHE A 36 80.77 55.64 REMARK 500 2 TYR A 3 41.17 -103.26 REMARK 500 2 ASN A 5 39.69 -148.14 REMARK 500 2 LYS A 11 -61.46 22.55 REMARK 500 2 TRP A 18 -70.49 65.55 REMARK 500 3 LYS A 11 -84.27 77.73 REMARK 500 3 SER A 12 22.68 -153.44 REMARK 500 3 TRP A 18 -60.71 65.90 REMARK 500 3 PHE A 36 -155.83 72.29 REMARK 500 4 ASN A 5 38.94 -148.01 REMARK 500 4 CYS A 9 78.21 -119.39 REMARK 500 4 LYS A 11 -89.68 83.21 REMARK 500 4 SER A 12 20.79 -149.61 REMARK 500 4 TRP A 18 -64.93 17.21 REMARK 500 4 PHE A 36 112.22 77.42 REMARK 500 5 ASN A 5 33.25 -146.98 REMARK 500 5 LYS A 11 -85.38 87.57 REMARK 500 5 SER A 12 31.89 -150.49 REMARK 500 5 TRP A 18 -69.02 19.51 REMARK 500 5 ASN A 34 -46.86 -150.93 REMARK 500 5 PHE A 36 35.43 -162.21 REMARK 500 6 TYR A 3 42.20 -105.77 REMARK 500 6 ASN A 5 29.66 -146.47 REMARK 500 6 TRP A 18 -59.47 70.17 REMARK 500 7 ASN A 5 50.71 -107.55 REMARK 500 7 CYS A 9 79.21 -114.16 REMARK 500 7 LYS A 11 -87.26 83.05 REMARK 500 7 SER A 12 22.63 -150.92 REMARK 500 7 TRP A 18 -63.25 64.94 REMARK 500 7 ASN A 34 46.15 -152.22 REMARK 500 8 TYR A 3 40.53 -106.06 REMARK 500 8 ASN A 5 48.17 -147.91 REMARK 500 8 CYS A 9 65.24 -113.23 REMARK 500 8 LYS A 11 101.32 29.11 REMARK 500 8 SER A 12 -46.48 82.02 REMARK 500 8 TRP A 18 -63.43 62.41 REMARK 500 9 ASN A 5 45.95 -146.48 REMARK 500 9 TRP A 18 -64.94 66.31 REMARK 500 9 PHE A 36 45.39 -163.12 REMARK 500 10 ASN A 5 33.57 -146.48 REMARK 500 10 LYS A 11 -85.88 92.42 REMARK 500 10 SER A 12 26.50 -151.44 REMARK 500 10 TRP A 18 -63.92 68.26 REMARK 500 10 PHE A 36 -1.11 76.59 REMARK 500 REMARK 500 THIS ENTRY HAS 90 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2LEU RELATED DB: PDB REMARK 900 2LEU CONTAINS THE SAME PEPTIDE WITH A STRUCTURE BASED ON FEWER REMARK 900 CONTRAINTS. DBREF 1CW6 A 1 37 UNP P34034 LCCA_LEUGE 25 61 SEQRES 1 A 37 LYS TYR TYR GLY ASN GLY VAL HIS CYS THR LYS SER GLY SEQRES 2 A 37 CYS SER VAL ASN TRP GLY GLU ALA PHE SER ALA GLY VAL SEQRES 3 A 37 HIS ARG LEU ALA ASN GLY GLY ASN GLY PHE TRP HELIX 1 1 TRP A 18 ALA A 30 1 13 SHEET 1 A 2 HIS A 8 THR A 10 0 SHEET 2 A 2 GLY A 13 SER A 15 -1 O GLY A 13 N THR A 10 SSBOND 1 CYS A 9 CYS A 14 1555 1555 2.03 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1